Access cutting-edge endometrial cancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access endometrial cancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related endometrial cancer treatment provided free
This research study is studying a combination of targeted therapies as a possible treatment for estrogen-receptor positive (ER+) endometrial cancer and low-grade serous ovarian cancer. The drugs involved in this study are: * Abemaciclib (also known as Verzenio™) * Letrozole (also known as Femara®) * Metformin (also known as Glucophage®) * Zotatifin (also known as eFT226) * Gedatolisib (also known as PF-05212384)
Sponsor: Dana-Farber Cancer Institute
Check if you qualify for this endometrial cancer clinical trial in Boston, MA
If you're searching for endometrial cancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometrial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.